The U.S. Food and Drug Administration has approved the first generic version of Truvada, a combination pill used for both HIV treatment and prevention, but it will not soon hit pharmacy shelves, ...
The US Food and Drug Administration (FDA) has approved a generic form of the drug Truvada, an antiretroviral and pre-exposure prophylaxis (PrEP) from Gilead Sciences. The approval notice was posted on ...
Generic PrEP use could reduce new HIV acquisitions, save lives among young men who have sex with men
Anne Neilan, MD, a physician-scientist in the division of Infectious Diseases at Massachusetts General Hospital is the senior author of a recently published paper in Clinical Infectious Diseases, ...
About one in five new HIV diagnoses in the United States occur among youth ages 13 to 24 years. Young men who have sex with men (YMSM) are account for 81% of new diagnoses in this age group in 2019.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results